Dr Wee Joo Chng
is the Director of the National University Cancer Institute of Singapore at the National University Health System, Singapore. He is also associated with Cancer Science Institute (CSI), Singapore, National University of Singapore as the Deputy Director and as a Senior Principal Investigator. Dr Chng is also an Associate Professor in medicine at Yong Loo Lin School of Medicine, National University of Singapore. He is the Chairman of CSI Graduate Studies Committee in CSI, and is the Vice President of Singapore Society of Haematology.
He has a PhD from National University of Singapore. He has fellowships from the Royal College of Physicians, Edinburgh; Academy of Medicine, Singapore; and Royal College of Pathologist, UK. He also has a specialist Accreditation in Haematology, Singapore. His research interests focus around multiple myeloma, liquid tumour biology and therapeutics. He is associated with many professional committees, such as American Society of Haematology Scientific Committee on Plasma Cell Neoplasia, International Myeloma Working Group and Asian Myeloma Network.
Dr Chng is in the peer review committee of journals, such as Blood, Leukemia, Cancer Research, and Haemostasis and Thrombosis. He is also involved in the committee of Grant Review, Conference Organising Committee, Advisory Boards and Steering Committees of Global Clinical Trials. He has authored in more than 125 publications in many reputed journals, such as The New England Journal of Medicine, Cancer Cell, Blood, Leukemia, Nature Medicine, and Cancer Research. Dr Chng has also authored several book chapters, actively participated in clinical trials and has delivered talks on multiple myeloma in several national and international conferences. He has won multiple awards for his research both locally and internationally including the National Medical Research Council Clinician Scientist Award, The National University of Singapore Young Researcher Award and the Celgene Future Leaders in Haematology Award.